Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise

Thomas Flaig, MD, Named Chair of NCCN Bladder Cancer Panel

University of Colorado Cancer Center's Thomas Flaig, MD, has been named chair of the NCCN Clinical Practice Guidelines in Oncology Panel for Bladder Cancer, a group of 34 multidisciplinary bladder experts from NCCN Member Institutions that will...
12-Jul-2017 11:05 AM EDT Add to Favorites

NEJM Case Reports Show Promise of Cancer Immunotherapy to Treat Rare Lymphoma


Three case reports published in the New England Journal of Medicine demonstrate the promise of cancer immunotherapy in gray zone lymphoma, potentially paving the way for clinical trials utilizing this strategy in this and related conditions.
10-Jul-2017 11:05 AM EDT Add to Favorites

CU Cancer Center Chemoprevention Trial Hopes to Stop Lung Cancer Before It Starts


Ongoing clinical trial by University of Colorado Cancer Center investigators is evaluating the ability of an inhaled form of the pulmonary hypertension drug iloprost to prevent lung cancer.
14-Jun-2017 3:05 PM EDT Add to Favorites

Metastatic Breast Cancer Cells Use Hedgehog to ‘Evilize’ Docile Neighbors


University of Colorado Cancer Center study pinpoints promising link in the chain of hedgehog signaling that, when broken, could reduce the metastatic potential of breast cancer.
12-Jun-2017 12:05 PM EDT Add to Favorites

Dasatinib Excels in Worldwide Phase II Trial Against Pediatric CML


Worldwide phase II clinical trial results presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2017 show the promise of the second-generation drug dasatinib against pediatric CML. Of 113 pediatric patients studied, 75...
31-May-2017 4:05 PM EDT Add to Favorites

CONNECT Registry Shows Only 9 Percent Compliance with Genetic Testing Guidelines for Aml


Study presented at ASCO 2017 shows that only 9 percent of 259 evaluated AML patients received all seven of the NCCN-recommended genetic tests.
31-May-2017 5:05 PM EDT Add to Favorites

Brigatinib First Drug to Offer Over 1-Year Control of ALK-Positive Lung Cancer Post-Crizotinib


FDA approves brigatinib as a second-line therapy for ALK-positive non-small cell lung cancer
17-May-2017 11:05 AM EDT Add to Favorites

New Clinical Trial Framework Tests ‘Natural’ Cures for Cancer


A University of Colorado Cancer Center clinical trial is now recruiting prostate cancer patients who would otherwise be on a watch-and-wait protocol to test the ability of grape seed extract to slow the rise of prostate-specific antigen (PSA), a...
16-May-2017 12:45 PM EDT Add to Favorites

Our Experts on Newswise

Will One Bad Sunburn Give You Skin Cancer?


27-Jul-2015 11:05 AM EDT

Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing


An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!